Research graph
References from Dose escalation with an IMRT technique in 15 to 28 fractions is better tolerated than standard doses of 3DCRT for LAPC. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
2015 · External reference
Results and patterns of failure in patients treated with adjuvant combined chemoradiation therapy for resected pancreatic adenocarcinoma
10.1002/cncr.24410 · 2009 · External reference
High nuclear hypoxia-inducible factor 1 alpha expression is a predictor of distant recurrence in patients with resected pancreatic adenocarcinoma
10.1016/j.ijrobp.2014.11.004 · 2015 · External reference
DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer
10.1200/jco.2008.17.7188 · 2009 · External reference
Failure patterns in resected pancreas adenocarcinoma: lack of predicted benefit to SMAD4 expression
10.1097/sla.0b013e31827fe9ce · 2013 · External reference
Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib: The LAP07 randomized clinical trial
10.1001/jama.2016.4324 · 2016 · External reference
Comparison of chemoradiotherapy (CRT) and chemotherapy (CT) in patients with a locally advanced pancreatic cancer (LAPC) controlled after 4 months of gemcitabine with or without erlotinib: Final results of the international phase III LAP 07 study
10.1200/jco.2013.31.18_suppl.lba4003 · 2013 · External reference
Ablative radiotherapy doses lead to a substantial prolongation of survival in patients with inoperable intrahepatic cholangiocarcinoma: A retrospective dose response analysis
10.1200/jco.2015.61.3778 · 2016 · External reference
Prostate cancer radiation dose response: Results of the MD Anderson phase III randomized trial
10.1016/s0360-3016(02)02829-8 · 2002 · External reference
Hyperfractionated or accelerated radiotherapy in head and neck cancer: A meta-analysis
10.1016/s0140-6736(06)69121-6 · 2006 · External reference
Focal radiation therapy dose escalation improves overall survival in locally advanced pancreatic cancer patients receiving induction chemotherapy and consolidative chemoradiation
10.1016/j.ijrobp.2015.12.003 · 2016 · External reference
Intensity modulated radiation therapy reduces gastrointestinal toxicity in locally advanced pancreas cancer
10.1016/j.prro.2015.09.006 · 2016 · External reference
Intensity-modulated radiation therapy significantly improves acute gastrointestinal toxicity in pancreatic and ampullary cancers
10.1016/j.ijrobp.2009.10.043 · 2011 · External reference
Intensity-modulated radiotherapy for pancreatic adenocarcinoma
10.1016/j.ijrobp.2011.09.035 · 2012 · External reference
A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancer
10.1016/j.ijrobp.2012.02.051 · 2012 · External reference
Solutions that enable ablative radiotherapy for large liver tumors: Fractionated dose painting, simultaneous integrated protection, motion management, and computed tomography image guidance
10.1002/cncr.29878 · 2016 · External reference
A dosimetric analysis of dose escalation using two intensity-modulated radiation therapy techniques in locally advanced pancreatic carcinoma
10.1016/j.ijrobp.2006.01.003 · 2006 · External reference
Hypofractionated image-guided IMRT in advanced pancreatic cancer with simultaneous integrated boost to infiltrated vessels concomitant with capecitabine: A phase I study
10.1016/j.ijrobp.2013.09.012 · 2013 · External reference
Toward stratification of patients with pancreatic cancer: Past lessons from traditional approaches and future applications with physical biomarkers
10.1016/j.canlet.2015.12.006 · 2016 · External reference
Transport properties of pancreatic cancer describe gemcitabine delivery and response
10.1172/jci73455 · 2014 · External reference
Correlation of Smad4 status with outcomes in patients receiving erlotinib combined with adjuvant chemoradiation and chemotherapy after resection for pancreatic adenocarcinoma
10.1016/j.ijrobp.2013.06.2039 · 2013 · External reference
Induction chemotherapy followed by concurrent full-dose gemcitabine and intensity-modulated radiation therapy for borderline resectable and locally advanced pancreatic adenocarcinoma
10.1097/coc.0000000000000003 · 2016 · External reference
Preoperative modified FOLFIRINOX treatment followed by capecitabine-based chemoradiation for borderline resectable pancreatic cancer: Alliance for clinical trials in oncology trial A021101
10.1001/jamasurg.2016.1137 · 2016 · External reference
